Hyundai Oilbank’s IPO plan faces bumpy road Refiner needs to show investors growth potential of new businesses to raise value
Translated by Ryu Ho-joung 공개 2021-07-26 08:10:06
이 기사는 2021년 07월 26일 08:04 thebell 에 표출된 기사입니다.
Hyundai Oilbank has restarted a process to go public on the South Korean stock exchange with a target of listing in the first half of next year. But the difference in valuation expectations between the company and investors could increase the uncertainty about the success of the listing.It is a broadly shared view among bankers that Hyundai Oilbank’s valuation will be less based on subjective assumptions compared to those of companies in emerging industries such as electric vehicles and biotech pharmaceuticals. The traditional oil refining is the company’s core business, and Hyundai Oilbank and other three refiners maintain an oligopoly in the country’s refining industry.
Hyundai Oilbank held a 20.9% market share last year, after SK Innovation (29.9%), S-Oil (24%) and GS Caltex (23.6%). Among its three rivals, SK Innovation and S-Oil are listed on Kospi.
S-Oil is more comparable with the company than SK Innovation in terms of size and market share. S-Oil reported an operating profit of 629.2 billion won ($546.8 million) on revenue of 5.35 trillion won in the first quarter this year, versus Hyundai Oilbank’s operating profit of 412.8 billion won on revenue of 4.54 trillion won in the same period. S-Oil’s refining business accounted for 73% of its total revenue, similar to 74% for Hyundai Oilbank.
SK Innovation, which is SK Group’s energy holding company, is less likely to be considered as a peer as a sizable portion of the company’s revenue comes from its electric battery and materials businesses as well as refining. SK Innovation also has a market capitalization of around 23 trillion won, more than twice that of S-Oil.
Bankers are likely to use S-Oil’s price-to-earnings (P/E) ratio as a reference to estimate Hyundai Oilbank’s value.
S-Oil trades at a trailing P/E ratio of 24.79 based on its most recent trailing twelve-month net profit of 429.2 billion won and Wednesday’s closing price. Hyundai Oilbank’s value is estimated to be 7.34 trillion won based on its trailing twelve-month earnings and S-Oil’s trailing P/E ratio.
On a forward basis, the P/E ratio substantially declines due to an earnings recovery from the Covid-19 pandemic in the overall refining industry.
S-Oil’s 2021 earnings estimate – simply calculated as the first-quarter net profit multiplied by four – is 1.38 trillion won, which represents a forward P/E ratio of 7.72. Based on this P/E ratio and Hyundai Oilbank’s estimated 2021 net profit of 774.5 billion won, its value is estimated to be 5.98 trillion won.
Lofty IPO target
The problem is Hyundai Oilbank needs to set its valuation at trillions of won higher than 8 trillion won, at which it raised money from Aramco. In 2019, the Saudi oil giant bought 17% of Hyundai Oilbank for about 1.38 trillion won. The IPO price needs to value the company at 8 trillion won plus several trillions of won to make Aramco’s investment profitable.
Hyundai Oilbank relies on its new businesses to narrow the valuation gap. In March this year, the company announced Vision 2030 to reduce its revenue reliance on refining and increase an operating profit from future growth drivers – including white biotechnology, eco-friendly chemical materials and low-carbon blue hydrogen – to 70% of the total by 2030. It also decided to sell 90% of its oil storage business to J& Private Equity for 180 billion won earlier this month to use the proceeds for new business opportunities.
The IPO’s success is likely to depend on whether Hyundai Oilbank can show investors that its new businesses will drive future revenue growth.
“We have been stepping up efforts to secure new future growth engines and also successfully issued ESG bonds in the first half of this year,” said an official at Hyundai Oilbank. “We expect to share the progress of our new businesses with investors in the first half of next year.” (Reporting by Kyung-ju Lee)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [제약바이오 맨파워 분석]1세대 바이오텍 숙명 '승계', 리가켐바이오의 '후계양성'
- [K-바이오 클러스터 기행|대전]빅파마 찜한 바이오 다 모였다 '산·학·연' 집결 경쟁력
- [이스트소프트는 지금]SW에서 AI로 체질개선, 핵심은 '시니어 케어'
- [코스닥 코스메틱 리뉴얼]'2차전지·신재생·건설' 신사업 행렬, 돌파구 찾을까
- '비상장사' 네이처리퍼블릭, CB발행 선택 까닭은
- [바이어 人사이드]고물가·왕서방 '이중고' 유통가, 품질·가격 잡기 '사활'
- [전환기 맞은 CJ올리브영]점포 자연 증가 '생태계 구축', 온라인까지 확장
- 오리온, 배당정책 '개별→연결' 실익 따져보니
- 삼성물산 패션, '메종키츠네 골프' 1년 반 만 철수
- [카카오의 변신, 브라이언을 지워라]'MZ' 부각된 박새롬 사외이사, AI 열풍 속 커지는 역할